[go: up one dir, main page]

MX2018015344A - Composiciones y metodos que modulan las bacterias en un animal de compañía. - Google Patents

Composiciones y metodos que modulan las bacterias en un animal de compañía.

Info

Publication number
MX2018015344A
MX2018015344A MX2018015344A MX2018015344A MX2018015344A MX 2018015344 A MX2018015344 A MX 2018015344A MX 2018015344 A MX2018015344 A MX 2018015344A MX 2018015344 A MX2018015344 A MX 2018015344A MX 2018015344 A MX2018015344 A MX 2018015344A
Authority
MX
Mexico
Prior art keywords
compositions
methods
bacteria
companion animal
specific type
Prior art date
Application number
MX2018015344A
Other languages
English (en)
Inventor
P Middleton Rondo
S Hannah Steven
M Zanghi Brian
Andre Dominique Rezzi Serge
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018015344A publication Critical patent/MX2018015344A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Una bacteria específica en un animal de compañía puede mejorarse al ajustar la dieta del animal para aumentar la cantidad de un compuesto que modula positiva o negativamente el tipo específico de bacteria o para reducir la cantidad de un compuesto que modula positiva o negativamente el tipo específico de bacteria. El tipo específico de bacteria puede ser una o más de Bifidobacterium, Lactobacillus o Clostridium perfringens.
MX2018015344A 2016-12-15 2017-12-12 Composiciones y metodos que modulan las bacterias en un animal de compañía. MX2018015344A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662434560P 2016-12-15 2016-12-15
PCT/IB2017/057848 WO2018109665A1 (en) 2016-12-15 2017-12-12 Compositions and methods that modulate bacteria in a companion animal

Publications (1)

Publication Number Publication Date
MX2018015344A true MX2018015344A (es) 2019-04-29

Family

ID=60935914

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015344A MX2018015344A (es) 2016-12-15 2017-12-12 Composiciones y metodos que modulan las bacterias en un animal de compañía.

Country Status (11)

Country Link
US (2) US20180168196A1 (es)
EP (1) EP3554254B1 (es)
JP (1) JP2020513730A (es)
CN (1) CN109414037A (es)
AU (1) AU2017376919A1 (es)
BR (1) BR112018076609B1 (es)
CA (1) CA3025172C (es)
ES (1) ES3027568T3 (es)
MX (1) MX2018015344A (es)
RU (1) RU2763296C2 (es)
WO (1) WO2018109665A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2953519T3 (es) 2016-12-15 2023-11-14 Nestle Sa Composiciones y métodos que modulan la vitamina D y el contenido mineral óseo en un animal de compañía
WO2018109666A1 (en) * 2016-12-15 2018-06-21 Nestec Sa Compositions and methods that modulate cholesterol in a companion animal
CN113518645A (zh) * 2019-02-28 2021-10-19 森永乳业株式会社 双歧杆菌属细菌的菌毛形成诱导用的组合物
CN112820348B (zh) * 2021-01-06 2023-04-07 宁夏医科大学总医院 一种检测血浆代谢与银屑病患者皮肤微生物区系相互作用的方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869546A (en) 1972-12-22 1975-03-04 Cutter Lab Adjuvant compositions and medicinal mixtures comprising them
CA2183684C (en) 1994-02-18 2008-07-15 Richard D. Hansen Inoculation of animals with dried, pelleted biological materials
DE69739394D1 (de) 1996-10-16 2009-06-18 Napo Pharmaceuticals Inc Enteral-formulierungen von proanthocyanidzusammensetzungen gegen diarrhöe
AU4188199A (en) 1998-05-15 1999-12-06 University Of California, Los Angeles Type iii (bordetella) secretion system
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
US6172040B1 (en) 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
DE60038048T2 (de) 1999-12-21 2009-07-09 Merial Mindestens ein cryptosporidium parvum-antigen und mindestens ein antigen eines anderen darmkrankheitserregers enthaltende zusammensetzungen und impfstoffe
US20050106163A1 (en) 1999-12-21 2005-05-19 David Frederic R.M. Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen
AP2002002652A0 (en) 2000-04-27 2002-12-31 Pfizer Prod Inc The use of azalide antibiotic composition for treating or preventing a bacterial or protozoal infection in mammals.
MY128159A (en) 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
EP1654000A1 (en) 2003-08-14 2006-05-10 Merial Limited Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen
EP2279736A1 (en) 2004-03-12 2011-02-02 Life Science Investments Ltd. Microbicidal and antiparasitic compositions comprising quassinoids or quassionid-containing plant extracts
US20050249842A1 (en) 2004-05-08 2005-11-10 Abrahamsen Jill M Ingredient pakaging
AU2005333156B2 (en) 2004-11-03 2011-05-26 Iris Molecular Diagnostics, Inc. Homogeneous analyte detection
US8052971B2 (en) 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
EP2170402B1 (en) 2007-06-26 2015-03-25 Children's Medical Center Corporation Metap-2 inhibitor polymersomes for therapeutic administration
KR101008480B1 (ko) 2007-12-28 2011-01-14 원광대학교산학협력단 항균 활성을 갖는 오배자 추출물 또는 이로부터 분리된화합물을 유효성분으로 함유하는 조성물
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US8865865B2 (en) 2008-10-29 2014-10-21 Philipps-Universitat Marburg N-terminally modified tetrapeptide derivatives having a C-terminal arginine mimetic
EP2398892A4 (en) 2009-02-20 2013-03-06 Australian Poultry Crc Pty Ltd LIVING WEARED VACCINES
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
AU2010276259B2 (en) * 2009-07-21 2013-04-18 Hill's Pet Nutrition, Inc. Companion animal nutrition system
JP2013514085A (ja) * 2009-12-18 2013-04-25 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド プロバイオティックを含むペットフード組成物ならびにそれを調製および使用する方法
US8853269B2 (en) * 2010-02-04 2014-10-07 Copperhead Chemical Company Inc. Composition and method for treating infections and promoting intestinal health
US20120115798A1 (en) * 2010-11-04 2012-05-10 Stefan Patrick Massimino Method for improving the immunity of a companion animal
EP2709657B1 (en) 2011-05-17 2018-10-24 Soligenix, Inc. Thermostable vaccine compositions and methods of preparing same
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
WO2013070962A1 (en) * 2011-11-08 2013-05-16 The Board Of Regents Of The University Of Texas System Methods and uses for metabolic profiling for clostridium difficile infection
US20140328896A1 (en) 2011-12-29 2014-11-06 Hill's Pet Nutrition, Inc. Compositions and methods for modifying gastrointestinal flora
WO2013165921A2 (en) * 2012-04-30 2013-11-07 Sonomaceuticals, Llc Therapeutic use of chardonnay seed products
WO2014036182A2 (en) * 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
CA2900372C (en) 2013-02-08 2021-06-08 Luoda Pharma Pty Ltd Methods of treating topical microbial infections
US20140271815A1 (en) 2013-03-15 2014-09-18 Aryo Sorayya Heat-and freeze-stable vaccines and methods of making and using same
US20160143324A1 (en) * 2014-11-25 2016-05-26 Nestec Sa Methods and compositions for preserving lean body mass and promoting fat loss during weight loss
EP3223623A1 (en) * 2014-12-29 2017-10-04 Hill's Pet Nutrition, Inc. Food composition and method of use

Also Published As

Publication number Publication date
RU2018146220A (ru) 2020-06-25
WO2018109665A1 (en) 2018-06-21
CA3025172C (en) 2024-05-28
BR112018076609A2 (pt) 2019-04-16
EP3554254B1 (en) 2025-05-07
BR112018076609B1 (pt) 2023-02-14
EP3554254A1 (en) 2019-10-23
JP2020513730A (ja) 2020-05-21
US20200221736A1 (en) 2020-07-16
CA3025172A1 (en) 2018-06-21
RU2763296C2 (ru) 2021-12-28
AU2017376919A1 (en) 2018-12-13
ES3027568T3 (en) 2025-06-16
US11122821B2 (en) 2021-09-21
US20180168196A1 (en) 2018-06-21
CN109414037A (zh) 2019-03-01
RU2018146220A3 (es) 2021-07-05

Similar Documents

Publication Publication Date Title
SA520411910B1 (ar) تركيبات وطرق لعلاج اضطرابات مناعية باستخدام سلالات بكتيرية من المكورات اللبنية المعدلة للمناعة
MX2020009455A (es) Composiciones que comprenden cepas bacterianas.
MX2018015344A (es) Composiciones y metodos que modulan las bacterias en un animal de compañía.
MX2018015451A (es) Composiciones y metodos que modulan la digestibilidad en un animal de compañia.
PH12018500954A1 (en) Feed additive composition
MX2016006147A (es) Suplemento alimenticio.
MX2019014045A (es) Composiciones y metodos.
CO2020012513A2 (es) Composiciones y métodos para renovación de la piel
MX2009012694A (es) Composicones y metodos utiles para modular la inmunidad, mejorar la eficacia de vacunas, disminuir la morbilidad asociada con infecciones cronicas por fhv-1, y prevenir o tratar la conjuntivitis.
PH12016502062A1 (en) Compositions and methods for modulating completent factor b expression
BR112017023636A2 (pt) suplemento dietético
BR112017014649A2 (pt) ?isolado intestinal humano, e, composição?
MX2019011058A (es) Moleculas probioticas para reducir virulencia patogena.
PH12019500264A1 (en) Lactobacillus salivarius cjls1511, animal feed additive composition comprising same bacterium or dead cells thereof, and method for producing same dead cells
BR112018076326A2 (pt) composições e métodos que modulam fósforo ou enzimas em um animal de estimação
AR113983A1 (es) Tratamiento de desórdenes autónomos
CL2018002688A1 (es) Beta-caseinas y función cognitiva
SG10201808326QA (en) Nutrition composition
CO2018001271A2 (es) Composición microbiana de microorganismos probióticos
PL414701A1 (pl) Nowy szczep Lactobacillus plantarum AMT14 i kompozycja zawierająca szczep Lactobacillus plantarum AMT14
MX2018007780A (es) Composiciones y metodos de uso de cepas novedosas de lactobacillus fermentum.
AR095486A1 (es) Composición nutricional para el tratamiento de emesis idiopática crónica en felinos y canes
UY35631A (es) ?composición de solución de rehidratación oral que contiene probióticos?.
CL2020001958A1 (es) Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas.
MX2018012312A (es) Lactobacillus rhamnosus para su uso en la preparacion de productos fermentados.